![Saxagliptin Market](https://ttalkus.com/wp-content/uploads/2023/04/saxagliptin-market.png)
The ‘Global Saxagliptin Market Report and Forecast 2023-2028’ by Expert Market Research gives an extensive outlook of the global saxagliptin market trends, assessing the market on the basis of its segments like dosage, distribution channels, and major regions.
The report studies the latest updates in the market, along with their impact across the market. It also analysis the market demand, together with its price and demand indicators. The report also tracks the market on the bases of SWOT and Porter’s Five Forces Models.
The key highlights of the report include:
Market Overview (2018-2028)
- Forecast CAGR (2023-2028): 4%
Saxagliptin Industry Definition and Major Segments
Saxagliptin is defined as a drug which is used to treat diabetes mellitus. It belongs to the medication class known as dipeptidyl peptidase-4 and is taken along with food to alter the blood sugar levels of a person. This medication also has positive impacts such as reduced risk of heart disease, stroke, or nerve damage, among others. Based on dosage, the market can be segmented into:- 2.5 mg
- 5 mg
- Others
- Hospital Pharmacy
- Retail Pharmacy
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Saxagliptin Market Trends
The key trends in the global saxagliptin market include the growing research and development activities by the major pharmaceutical companies aimed towards increasing the efficacy of formulations to boost the treatment of diabetes mellitus. The increasing healthcare expenditure, growing healthcare awareness, and rising disposable income across the emerging economies are some of the crucial trends bolstering the market growth. In addition to this, the increasing geriatric population and sedentary lifestyles and the associated risk of diabetes, coupled with the favourable government policies are some of the other factors propelling the demand for saxagliptin. Meanwhile, the thriving e-commerce industry as well as efficient pharmaceutical home delivery apps is likely to accelerate the saxagliptin market in the forecast period. Additionally, the rapid development of hospital pharmacies and rapid urbanisation are likely to further augment the value chain of saxagliptin in the coming years. Over the forecast period, the growing FDA approvals of Saxagliptin formulations and tablets are likely to be the major trends garnering the saxagliptin market. For instance, Glenmark Pharmaceuticals Inc., announced that the company has been granted a tentative approval by the FDA for its 10/5 mg Saxagliptin tablets. However, the side-effects of the medicine such as itching, rashes, and vomiting, among others, are likely to pose a challenge to the market.Key Market Players
The major players in the saxagliptin market report are:- AstraZeneca plc.
- Wellona Pharma
- Others